Clinuvel Pharmaceuticals Ltd. carries a market capitalization of 347.95M, placing it among publicly traded companies globally.
| Market Cap | 347.95M |
| Enterprise Value | N/A |
Clinuvel Pharmaceuticals Ltd.'s stock has declined approximately -2.12766% over the past 52 weeks. The 50-day moving average sits at 6.96, while the 200-day moving average is 7.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | -2.12766% |
| 50-Day Moving Average | 6.96 |
| 200-Day Moving Average | 7.29 |
| Average Volume (20 Days) | N/A |